Oral med for obesity, stem cells after heart failure, blood markers and MS, and predicting atherosclerosis

Voices and OpinionResearch Spotlight
Written By David Peregrino

This week's topics include an oral medication for obesity, stem cells after MI and heart failure, blood markers and MS, and beyond BMI for atherosclerosis.

Program notes:

0:37 An oral med for obesity

1:37 Five to 10% stopped medication

2:35 Need head-to-head trials with injectable

3:00 Stem cell infusion after MI and heart failure

4:01 Reduced heart failure in recipients

5:01 Twice as many in the control arm

6:01 Moving past BMI in predicting atherosclerosis

7:01 Especially in overweight but not obese

8:01 Almost 3000 participants in Brazil

8:25 Blood samples precede MS

9:04 Seen seven years beforehand

10:02 Twin studies and relatives

11:03 Way to intervene earlier

11:15 Applaud OpenAI

13:00 End

David Peregrino
Next

AI and diabetes, knee OA exercises, Mediterranean diet, IBS, and steps for health